LS Innoventa SRL
11.8 FTELS Innoventa reported total assets of €5.35m at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Jul 2026), with 11.8 full-time equivalents.
The score of LS Innoventa shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +132 % Total assets +117 % Headcount (avg FTE) +111 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
LS Innoventa's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jul 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
- Year ended 31 Dec 2023filed on 10 Jul 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
- Year ended 31 Dec 2021filed on 25 Jul 2022
LS Innoventa's financial analysis
- Solvency37.8%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of LS Innoventa
LS Innoventa's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0665.643.296
- VAT number
- BE0665643296
- Peppol
- Registered · 0208:0665643296 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 31 Oct 2016
- Registered office
- 3600 Genk
- Size
- Small · 11.8 FTE
- Latest accounts
- 2025 · filed on 15 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
LS Innoventa (SRL) has been based in Genk since 2016, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of €2.18m and equity of €2.02m; its revenue is not published. With 11.8 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 37.8%, below the median of its sector (46.0%).
Companies similar to LS Innoventa
Companies in the same business, of comparable size and area, outside its group.
- Dialex Biomedica Wholesale of pharmaceutical and medical goods Bilzen-Hoeselt · balance sheet €7.97m
- Aguettant SA/NV Wholesale of pharmaceutical and medical goods Brussels · balance sheet €4.15m
- WM Supplies (B) Wholesale of pharmaceutical and medical goods Kuurne · balance sheet €3.17m
- Enovis Surgical Belux Wholesale of pharmaceutical and medical goods Leuven · balance sheet €9.19m
- Phytos Wholesale of pharmaceutical and medical goods Kortrijk · balance sheet 2,672 €
- Prodivet Pharmaceuticals Wholesale of pharmaceutical and medical goods Raeren · balance sheet €3.32m
- DJO Benelux Wholesale of pharmaceutical and medical goods Geel · balance sheet €4.03m
- BO Medicals Wholesale of pharmaceutical and medical goods Lier · balance sheet €2.55m
Frequently asked questions about LS Innoventa
What is the revenue of LS Innoventa?
LS Innoventa files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of LS Innoventa?
In Belgium, the VAT number is the company number prefixed with BE: BE0665643296 for LS Innoventa, if the company is VAT-registered. Its company number (CBE) is 0665.643.296.
Where is the registered office of LS Innoventa?
According to the CBE register, the registered office of LS Innoventa is in 3600 Genk.
What is the equity of LS Innoventa?
At the close of the 2025 financial year, the equity of LS Innoventa amounts to 2,023,977 €, a solvency of 37.8% of total assets.
How many people work at LS Innoventa?
11.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages LS Innoventa?
The register lists 1 active mandates at LS Innoventa. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of LS Innoventa
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →